# Overall survival in patients with glioblastoma before and after bevacizumab approval

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/overall-survival-in-patients-with-glioblastoma-before-and-after-bevacizumab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Derek R. Johnson,Antonio Omuro,Arliene Ravelo,Nicolas Sommer,Annie Guérin,Raluca Ionescu‐Ittu,Sherry Shi,Alex Macalalad,Joon H. Uhm |
| Citations | 42 |
| DOI | 10.1080/03007995.2017.1392294 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2760893789 |
| PMID | 29025274 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Sherry Shi](https://scholariq.org/researchers/sherry-shi/)

## Paper journal

- [Current Medical Research and Opinion](https://scholariq.org/journals/current-medical-research-and-opinion/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.